Plain-English translation of NCT05320926 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing what happens after you receive a special heart stent called a zotarolimus-eluting Onyx stent to treat blocked arteries. After your stent is placed, you'll take two blood-thinning medications together for 1 to 3 months. Then, researchers want to see whether continuing with clopidogrel alone or aspirin alone works better to prevent future heart problems over the next year.
After heart stent placement, doctors typically prescribe two blood thinners to prevent clots, but this increases the risk of bleeding. This trial is trying to figure out which single blood thinner is safer and more effective after a short period of taking both, especially for patients who are at high risk of bleeding.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups when you enter the hospital for your stent procedure. For the first 1 to 3 months, everyone takes two blood-thinning medications together. After that initial period, your group will switch to taking only one of these medications for the remainder of the year. You'll be monitored for one year total to track whether you experience any heart problems or serious bleeding, with follow-up appointments to assess your progress.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
South Korea